BFA
TMO icon

Beaumont Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Beaumont Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
2,039
-1,028
-34% -$493K 0.07% 170
2026
Q1 		$1.51M Buy
3,067
+1,002
+49% +$544K 0.1% 123
2025
Q4 		$1.2M Sell
2,065
-651
-24% -$368K 0.08% 149
2025
Q3 		$1.32M Buy
2,716
+557
+26% +$259K 0.09% 136
2025
Q2 		$875K Sell
2,159
-87
-4% -$36.4K 0.06% 164
2025
Q1 		$1.12M Buy
2,246
+225
+11% +$122K 0.09% 135
2024
Q4 		$1.05M Buy
2,021
+402
+25% +$221K 0.08% 145
2024
Q3 		$1M Sell
1,619
-603
-27% -$357K 0.08% 145
2024
Q2 		$1.23M Buy
2,222
+23
+1% +$13.2K 0.1% 130
2024
Q1 		$1.28M Buy
2,199
+17
+0.8% +$9.54K 0.11% 124
2023
Q4 		$1.16M Buy
2,182
+33
+2% +$16K 0.11% 127
2023
Q3 		$1.09M Buy
2,149
+136
+7% +$72.5K 0.11% 116
2023
Q2 		$1.05M Buy
2,013
+76
+4% +$41K 0.1% 128
2023
Q1 		$1.12M Buy
1,937
+27
+1% +$15.2K 0.11% 106
2022
Q4 		$1.05M Sell
1,910
-9
-0.5% -$4.77K 0.11% 115
2022
Q3 		$973K Sell
1,919
-36
-2% -$20.1K 0.09% 116
2022
Q2 		$1.06M Sell
1,955
-124
-6% -$68.3K 0.1% 120
2022
Q1 		$1.23M Buy
2,079
+714
+52% +$410K 0.09% 140
2021
Q4 		$911K Sell
1,365
-330
-19% -$206K 0.07% 153
2021
Q3 		$974K Sell
1,695
-299
-15% -$164K 0.08% 140
2021
Q2 		$1.01M Buy
1,994
+142
+8% +$67K 0.08% 144
2021
Q1 		$845K Sell
1,852
-379
-17% -$181K 0.07% 157
2020
Q4 		$1.04M Buy
2,231
+1,700
+320% +$797K 0.09% 133
2020
Q3 		$235K Sell
531
-48
-8% -$19.8K 0.02% 287
2020
Q2 		$210K Buy
+579
New +$194K 0.02% 265
2020
Q1 		– Sell
-652
Closed -$212K – 287
2019
Q4 		$212K Buy
+652
New +$198K 0.02% 263

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Beaumont Financial Advisors's TMO Position: Q2 2026 in Review

Beaumont Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 34% in Q2 2026, selling an estimated $493K and leaving 2,039 shares worth $1.02M. The position accounts for 0.07% of the portfolio, ranked #170.

Beaumont Financial Advisors first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.51M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Beaumont Financial Advisors held 2,039 shares of Thermo Fisher Scientific worth $1.02M as of Q2 2026.
  • Beaumont Financial Advisors sold 1,028 Thermo Fisher Scientific shares in Q2 2026, an estimated $493K.
  • Thermo Fisher Scientific made up 0.07% of Beaumont Financial Advisors's portfolio in Q2 2026, its #170 holding.
  • Beaumont Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • Beaumont Financial Advisors's Thermo Fisher Scientific position peaked at $1.51M in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Beaumont Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.